Perry Drug Recalls Compounded HCG Injections Due to Sterility Concerns
Perry Drug Inc. is recalling compounded HCG injections in Kansas and Missouri due to potential sterility assurance issues identified during an FDA inspection.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance in sterile compounded products, which poses a significant risk of infection or serious injury, meeting the criteria for a Severe rating.
Plain-English summary
Perry Drug Inc. is recalling all lots of sterile products compounded by the pharmacy that are within their expiration date. The specific product identified is HCG - 10,000 Unit PF Inject, 1mL Syringe, Compounded Rx, manufactured by Perry Drug Compounding Pharmacy in Overland Park, Kansas. The recall affects NDC 88888-0216-49.
The recall was initiated due to concerns associated with quality control procedures that present a potential risk to sterility assurance. These concerns were observed during a recent FDA inspection. The agency has classified this recall as Class II.
The affected products were distributed in Kansas and Missouri. Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for instructions on return or disposal.
The recalled product
- Product
- HCG - 10,000 Unit PF Inject, 1mL Syringe, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS NDC 88888-0216-49
- Manufacturer
- Perry Drug Inc.
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 141021CC
- 11/21/14
Distribution
Part of a larger recall action
This product is one of 17 recalled by Perry Drug Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 17 products in this recall →Related recalls
Same manufacturer · Perry Drug Inc.
See all →- SeverePerry Drug Recalls Cyclosporine Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2014-12-03
- SeverePerry Drug Recalls Tri-mix Antidote Syringes Due to Sterility Concerns
FDA (Drugs) · 2014-12-03
- SeverePerry Drug Recalls HCG Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-12-03
- SeverePerry Drug Recalls Methyl B12 Syringes Due to Sterility Concerns
FDA (Drugs) · 2014-12-03
- SeverePerry Drug Recalls Phenylephrine Syringes Due to Sterility Concerns
FDA (Drugs) · 2014-12-03
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SevereHCG Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereHCG Injection Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereCompounded HCG Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereHCG Injection Recalled for Potential Sterility Issues
FDA (Drugs) · 2015-09-23
- HighCompounded HCG and B-12 Injection Recalled for Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereUS Compounding Recalls Phenylephrine PF Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-25